Celanese Corporation research snapshot
CE AI stock analysis currently reads Celanese Corporation as a cyclical specialty chemicals producer with durable product positions, very high debt from M&A, and negative TTM earnings that are expected to improve. The analysis is not a certain price prediction. At the August 4, 2026 cutoff, the latest verified close was $43.89 on August 3, 2026. Market capitalization was about $4.81 billion against an enterprise value of $15.96 billion, with $12.91 billion of total debt and $1.76 billion of cash. Celanese still generates positive free cash flow of about $878 million TTM, but the balance sheet is stretched and the dividend was cut to $0.12 per year. Q2 2026 results are scheduled after the market close on August 4, 2026, with the conference call on August 5. This is informational research and not investment advice.
Current price
$43.89
Market cap
$4.81 billion
AI score
42 / 100
Rating
Cyclical chemicals turnaround with high leverage
Trend status
Below the 50-day and 200-day moving averages after a sharp pullback
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Celanese produces engineered polymers and acetyl chemicals with leading positions in POM, LCP, UHMW-PE, acetic acid, and VAM. Products serve auto, medical, electronics, and construction end markets. TTM revenue is $9.49 billion with negative net income of -$1.10 billion. | High |
| Moat | Moat comes from proprietary polymer technology, long customer qualifications, an integrated acetyl chain cost position, and brand heritage with trademarks like Celcon, Hostaform, and Vectra. Product switching costs are moderate to high in engineered materials. | Medium-high |
| Management | Management is focused on cash generation, debt reduction, cost optimization, and synergy delivery from the DuPont M&M acquisition. Recent steps include closing the Ulsan compounding facility, announcing price increases, and cutting the dividend to preserve cash. The Amsterdam court dismissed the Shell and Repsol damages claims on July 30, 2026, removing a litigation overhang. | Medium |
| Financial trend | TTM revenue of $9.49 billion with negative net income of -$1.10 billion and EPS of -$10.01, driven by impairments and amortization from acquisitions. Operating cash flow of $1.19 billion and free cash flow of $878 million show cash generation capacity. Debt-to-equity is 288% and interest coverage is negative. | High |
| Valuation | TTM P/E is not meaningful at -4.4x due to losses, forward P/E is about 6.8x, P/B is 1.18x, P/FCF is 5.5x, and FCF yield is about 18%. Book value per share is about $37.05. The low forward multiple reflects expected earnings recovery, while the negative interest coverage reflects the debt load. | Medium |
| Technical trend | CE traded near $43.89, within the 52-week range of $35.13 to $70.70. Down 9.6% over the past year and down about 36.6% over three months from the May 2026 high. Price is below both the 50-day moving average of $49.01 and the 200-day of $50.11, with an RSI near 38.6. | Medium |
| Risk level | Elevated. Debt-to-equity of 288%, total debt of $12.91 billion, negative TTM earnings, a dividend cut, commodity chemical cyclicality, auto industry concentration, and China/Asia demand exposure. The Altman Z-score of 1.48 signals higher financial distress risk, though the company keeps generating positive operating cash flow. | High |
| AI confidence | High confidence on balance sheet, revenue, cash flow, and price data. Lower confidence on near-term earnings recovery timing, impairment outlook, and the speed of chemical cycle recovery. | High data confidence |
| Investment certainty | Low. Very high leverage and cyclical end markets make CE a high-risk name. A recovery thesis depends on FCF stability, debt reduction, and end-market demand, and the dividend cut signals cash conservation. Not suitable for conservative portfolios without a wide margin of safety. | Low |
CE AI stock forecast
The CE AI stock forecast uses scenario ranges around the $43.89 cutoff price. It does not claim that AI can predict a specific future price. The bullish case requires earnings to beat consensus, FCF to stay near current levels, and debt to come down. The base case assumes gradual improvement with leverage still high. The bearish case assumes a demand downturn or renewed impairments.
$60 to $75
More likely if Q2 and Q3 2026 earnings beat the consensus adjusted EPS near $2.21 per quarter, free cash flow remains above $800 million, debt is reduced meaningfully, acetyl chain and engineered materials volumes recover, and the market re-rates CE toward the average analyst target of $67.50.
$42 to $55
More likely if earnings normalize gradually toward consensus full-year EPS of about $6.05, leverage stays high but manageable, the dividend remains at $0.12, and the stock trades around a mid-single-digit to low-double-digit forward P/E with a double-digit FCF yield.
$30 to $38
More likely if a recession or end-market downturn pressures volumes, impairments recur, debt covenants tighten, interest coverage stays negative, or the company signals it needs more cash conservation beyond the dividend cut already made.
CE AI technical analysis
CE AI technical analysis starts from the $43.89 August 3, 2026 close used for this August 4 static page. Public technical sources showed the stock below both its 50-day and 200-day moving averages after a sharp pullback from the May high, with RSI near 38.6. Because this page does not fetch request-time market data, traders should confirm levels on a live chart before acting.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $43.89 | Latest verified close on August 3, 2026, used as the data cutoff reference for this page. |
| Near support | $42.25 to $43.40 | The daily support zone from technical turning point data. A hold above this area suggests stabilization near the recent lows. |
| Key support | $35.13 | The 52-week low from November 18, 2025. A sustained break below this level would open a new lower trading range. |
| Near resistance | $44.60 to $45.70 | The first set of technical resistance points. A close above this band would signal the short-term downtrend may be easing. |
| Key resistance | $48.70 to $49.00 | The 38.2% Fibonacci level of $48.72 and the 50-day moving average of $49.01. A reclaim of the 50-day average would be the first meaningful bullish signal. |
| Secondary resistance | $52.90 to $57.10 | The 50% Fibonacci level of $52.92 and the 61.8% level of $57.11. Recovery toward these levels would require a fundamental re-rating. |
| Moving averages | 50-day $49.01, 200-day $50.11 | Price is below both averages. The 200-day average is now above the 50-day, reflecting the prolonged downtrend. |
| Momentum | 1M -7.95%, 3M -36.61%, 52W -9.60%, RSI 38.57 | RSI near 38.6 is weak but not yet oversold. The sharp three-month decline reflects the move from the $70.70 May high. |
| Volume | About 2.14 million shares on Aug 3 vs 1.80 million 20-day average | Slightly above-average volume on a down day suggests continued selling pressure into the earnings report. |
| Volatility | Beta 0.76, options implied volatility near 65% | Beta below 1.0 suggests lower market sensitivity, but options pricing implies an expected range of about $39.20 to $48.58 over the near term ahead of earnings. |
| Short interest | 7.81 million shares, 7.13% of shares outstanding | Days to cover of about 4.5. Elevated short interest can amplify both downside and short-covering rallies. |
| Invalidation | Close below $42 or sustained break below $35 | A close below $42 weakens the near-term outlook. A break below $35.13 would challenge the whole recovery thesis. A reclaim of $49 would signal a trend shift. |
CE AI trading strategy
The CE AI trading strategy is a rules-based framework, not personalized advice. It combines earnings-event risk, mean-reversion logic near support, balance-sheet monitoring, position sizing, and clear invalidation levels.
Q2 2026 results are scheduled after the market close on August 4, 2026, with the call on August 5. Consensus expects adjusted EPS near $2.21 versus $1.44 a year ago. Watch adjusted EPS, free cash flow, debt paydown, acetyl chain pricing, and forward guidance. Deutsche Bank issued a short-term catalyst Buy call ahead of the report.
Do not position ahead of earnings without a defined stop. CE can move sharply on results given its high fixed-cost base, leverage, and the expected options range of about $39.20 to $48.58.
If CE holds the $42.25 to $43.40 support zone with RSI near the high-30s, look for volume exhaustion, insider or institutional accumulation, or a positive earnings reaction as confirming signals before considering a position.
Position size must reflect the elevated balance-sheet risk. Define maximum loss based on a close below $42, with a wider invalidation near the $35.13 52-week low.
Track quarterly free cash flow (TTM $878 million), net debt of about $11.15 billion, debt-to-equity of 288%, interest coverage, impairment charges, acetyl chain and engineered materials volume, and dividend coverage. The key question is whether CE can reduce debt while maintaining operations.
Reduce exposure if FCF turns negative, debt increases, interest coverage stays negative while earnings disappoint, or end-market demand shows sustained deterioration.
Investment research summary
Celanese converts commodity acetyl feedstocks and engineered polymer technology into specialty materials that customers qualify into automotive, medical, electronics, and industrial products over multi-year cycles. Customers pay for performance, reliability, and multi-year qualification stability rather than spot commodity price.
The moat comes from proprietary polymer technology (POM, LCP, UHMW-PE), long product qualification cycles, integrated acetyl chain cost advantages, and brand heritage with trademarks like Celcon, Hostaform, and Vectra. The moat is durable but narrow, and it does not protect earnings from the commodity side of the acetyl chain or from a weak industrial cycle.
The thesis can fail if demand from auto, electronics, or construction weakens, integration from the DuPont M&M acquisition falls short, high debt restricts financial flexibility, impairments recur, interest costs overwhelm operating income, or a recession pressures chemical margins broadly. The dividend cut is an early signal that cash is being conserved.
Management is executing a Grow and Fortify strategy centered on cash generation, cost optimization, and debt reduction. Steps include closing the Ulsan compounding facility, announcing engineered materials and acetyl chain price increases, and cutting the quarterly dividend to $0.03. On July 30, 2026, the Amsterdam District Court dismissed the Shell and Repsol damages claims against Celanese and its co-defendants, removing a major litigation overhang.
Specialty chemicals demand is tied to industrial production, auto builds, electronics, and construction. The industry is mature but offers niche growth in engineering plastics, lightweighting, and sustainability-focused products like CO2-based POM. It is not a paradigm-shift industry, so long-term value depends on cost position and cycle discipline.
At a $43.89 price, 288% debt-to-equity, negative TTM earnings, and a $0.12 dividend, CE offers no wide margin of safety for conservative investors. A forward P/E of about 6.8x and a P/FCF of about 5.5x reflect the market expecting earnings recovery, but the negative interest coverage and net debt of about $11.15 billion leave equity exposed to adverse scenarios.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| CE price | $43.89 close on August 3, 2026 | StockAnalysis.com quote and Barchart.com quote | August 4, 2026 |
| Market capitalization | $4.81 billion, verified as $43.89 x 109.66 million shares | financial_rigor.py market cap verification | August 4, 2026 |
| Enterprise value | $15.96 billion | StockAnalysis.com statistics (S&P Global data) | August 4, 2026 |
| Revenue (TTM) | $9.49 billion | StockAnalysis.com statistics, cross-validated with Barchart.com | August 4, 2026 |
| Net income (TTM) | -$1.10 billion | StockAnalysis.com statistics | August 4, 2026 |
| Diluted EPS (TTM) | -$10.01 | StockAnalysis.com statistics | August 4, 2026 |
| Cash and cash equivalents | $1.76 billion | StockAnalysis.com balance sheet (Fiscal.ai data) | August 4, 2026 |
| Total debt | $12.91 billion | StockAnalysis.com statistics | August 4, 2026 |
| Net debt | -$11.15 billion, or -$101.65 per share | StockAnalysis.com statistics | August 4, 2026 |
| Debt / equity | 2.88 (288%) | StockAnalysis.com statistics | August 4, 2026 |
| Free cash flow (TTM) | $878 million, $8.01 per share | StockAnalysis.com statistics | August 4, 2026 |
| Forward P/E | 6.79x | StockAnalysis.com statistics | August 4, 2026 |
| Book value per share | Approximately $37.05 | StockAnalysis.com statistics and balance sheet | August 4, 2026 |
| Dividend | $0.12 annual ($0.03 quarterly), yield 0.27% | StockAnalysis.com and Barchart.com dividend data | August 4, 2026 |
| Valuation math | TTM P/E -4.38x, P/B 1.18x, P/FCF 5.48x, FCF yield 18.24%, ROE -27.0% from financial_rigor.py | financial_rigor.py valuation verification | August 4, 2026 |
| 52-week price range | $35.13 to $70.70 | StockAnalysis.com and Barchart.com price history | August 4, 2026 |
| Moving averages and RSI | 50-day $49.01, 200-day $50.11, RSI 38.57 | StockAnalysis.com statistics | August 4, 2026 |
| Analyst consensus | Buy rating, average target $67.50 (range $48 to $95), 16 analysts | StockAnalysis.com forecast (S&P Global and TipRanks data) | August 4, 2026 |
| Q2 2026 earnings | Report scheduled after market close August 4, 2026; call August 5, 2026 | StockAnalysis.com earnings date and Celanese press release | August 4, 2026 |
| Legal development | Amsterdam District Court dismissed Shell and Repsol damages claims on July 30, 2026 | Celanese press release via Business Wire | August 4, 2026 |
This CE AI stock analysis is an informational tool for research and education only. It is not investment advice, a recommendation, or a guarantee of future performance. Forecast ranges are scenarios based on available data as of August 4, 2026 and can be wrong. Chemicals businesses are cyclical, leverage introduces additional risk, and earnings results scheduled for August 4, 2026 could change the setup significantly.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
